ALLOX
@ALLOXbio
all our switches
🗣️ “We will generate innovative therapies for currently untreatable diseases” says @ALLOXbio's CEO, @JuliaDiumenge. 💊 We talked with her about the mission of this @CRGenomica #spinoff: creating more efficient drugs. Read the full interview here 👇 ellipse.prbb.org/julia-domingo-…
Big news!! I can finally officially announce that a few weeks ago, ALLOX @ALLOXbio was co-founded by the brilliant André Faure @aj4re , Pablo Baeza @pbcenturion , Ben Lehner @BenLehner , and myself, who will be stepping in as CEO of the company.
🆕 ALLO X, a new CRG spin-off with the support of @AsabysPartners The company is developing a proprietary platform technology to design new drugs targeting protein allosteric sites to treat cancer and potentially many other diseases. 🔗 lnkd.in/edFhDade
Asabys impulsa Allox, una 'spin-off' del Centre de Regulació Genòmica ara.cat/1_4a575b?utm_s… via @diariARA
At @ALLOXbio we now have 3 computational positions available! 📌Structural Bioinformatics Scientist 👉 tinyurl.com/3rs46j4t 📌Platform Bioinformatician 👉 tinyurl.com/nyvazbke 📌Computational Chemist 👉 tinyurl.com/5n6vpem3 Apply or repost to help us spread the word 🙏
🧪 Are you passionate about molecular cloning? 🧬 Are you interested in applying ingenious methods for generating mutant libraries? 💊 Are you excited to join an exceptional team of scientists committed to revolutionising drug discovery? If so, here is a new job opportunity 👇
The genetic architecture of protein stability by @aj4re @ainamartiaranda @cristonah @ToniBeltran13 @JoernSchmiedel nature.com/articles/s4158… @CRGenomica @sangerinstitute @ALLOXbio
Come and join the extraordinary team of ALLOX and help us accelerate the discovery of more effective therapies! 👉allox.bio/careers
Our team in #Barcelona is expanding & we're #hiring 2 talented scientists to fill these exciting new positions: a Lead Scientist & a Research Associate. Do u want to make a real difference in the future of applied high-throughput genetics and therapeutics? #PhdChat #ScienceJobs
We have two new openings for scientists in our growing team @ALLOXbio ! 📈 Please RT and help us spread the word 🙏🏼
Our team in #Barcelona is expanding & we're #hiring 2 talented scientists to fill these exciting new positions: a Lead Scientist & a Research Associate. Do u want to make a real difference in the future of applied high-throughput genetics and therapeutics? #PhdChat #ScienceJobs
Look out for André (@aj4re), ALLOX Co-founder and CDO, presenting at the EMBO | EMBL AI and biology Symposium, on Wednesday, March 13th at 14:15! 👉allox.bio/news/allox-to-… He will talk about a core building block of the ALLOX computational platform: 👉biorxiv.org/content/10.110…
"Como en La guerra de las galaxias, los científicos ya tienen un plano y un punto débil. Ahora necesitan fabricar un torpedo."🚀🌑 Orgulloso de haber contribuido a este primer mapa alostérico de KRAS — Estrella de la Muerte — encabezado por @WengChenchun @BenLehner @AlbertIltirda
Uno de cada dos hombres y casi una de cada tres mujeres tendrán cáncer a lo largo de su vida. En al menos uno de cada 10 casos, el tumor estará impulsado por mutaciones en el gen KRAS, descubierto en 1982. Ahora se revelan puntos débiles de la proteína elpais.com/ciencia/2023-1…
⚠️ Research Alert! ⚠️ Research Alert! New paper out in Nature reveals the "kill switches" of a protein misregulated in 10% of cancers! Super cool study led by the one and only @WengChenchun with the involvement of ALLOX co-founders @aj4re and @BenLehner nature.com/articles/s4158…
🔴 Revelados los puntos débiles de la proteína que provoca uno de cada 10 cánceres elpais.com/ciencia/2023-1…
Genómica e IA para luchar contra el cáncer lavanguardia.com/economia/20231…
